Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection Artwork

The Lancet Gastroenterology & Hepatology in conversation with

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

All Episodes

The Lancet Gastroenterology & Hepatology in conversation with

Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection

November 09, 2022 • The Lancet Gastroenterology & Hepatology

Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.

Read the full article:
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT)

Continue this conversation on social!

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv